Gastrointestinal Transit Times and Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transit
1 other identifier
observational
20
1 country
1
Brief Summary
The purpose of this study is to describe gastrointestinal (GI) motility in patients suffering from severe Ulcerative Colitis (UC) and to compare these results with similar results from a study on healthy subjects. Both studies are done with the use of Motilis 3D-Transit system which consists of a small electronic capsule ingested and detected by a receiver carried by the patient. Position and orientation of the capsule are interpreted by dedicated computer software and transit times, progression velocity and contraction frequencies can be revealed. The study is mainly descriptive and is designed to test and evaluate the usefulness of the Motilis 3D Transit system in UC patients and to tell us more about GI motility during severe inflammation. Motilis 3D-Transit system gives us a unique chance to study the gastrointestinal canal as a whole during severe illness. We expect to include 20 patients suffering from severe UC admitted to Hospital with the purpose of getting medical treatment. We do not expect any drop out, but in case of drop out a new patient will be included.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 27, 2012
CompletedFirst Posted
Study publicly available on registry
December 19, 2012
CompletedStudy Start
First participant enrolled
April 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedJanuary 7, 2014
January 1, 2014
1 year
November 27, 2012
January 6, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Velocity of progression through the inflamed part of the colon in severe UC compared to the velocity of progression in the corresponding colonic segment in healthy volunteers.
Three days from baseline visit
Secondary Outcomes (1)
Velocity of progression through the non-inflamed colonic segments in severe UC compared to the velocity of progression in the corresponding colonic segments in healthy volunteers.
Three days from baseline
Other Outcomes (1)
Velocity of progression through the small intestine in severe UC compared to velocity of progression through the small intestine in healthy volunteers.
three days from baseline visit
Study Arms (1)
Ulcerative Colitis
Interventions
Eligibility Criteria
Patients suffering from severe Ulcerative Colitis
You may qualify if:
- Severe Ulcerative colitis (modified Truelove and Witt score)
- Signed informed consent obtained
- Fasted since midnight
You may not qualify if:
- Known GI related symptoms complaints or GI diseases
- Swallowing disorders
- Cancer or other life threatening diseases or conditions
- Pregnancy or breast-feeding
- Previous abdominal surgery
- Abdominal diameter \>140cm?
- Drug abuse or alcoholism
- Irregular bowel movements
- Known cardiovascular or pulmonary diseases
- Participation in any clinical study within the last 30 days
- Cardiac pacemaker or infusion pump or any other implanted or portable electro-mechanical medical device.
- Medication affecting GI motility
- MRI within the next four weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aarhuslead
- Motilis Medica A/S ,Switzerlandcollaborator
Study Sites (1)
Aarhus University Hospital, Department of Hepato and Gastroenterolegy
Aarhus C, 8000, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
AnneMette Haase, Ph.d Student
Aarhus University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 27, 2012
First Posted
December 19, 2012
Study Start
April 1, 2013
Primary Completion
April 1, 2014
Study Completion
March 1, 2015
Last Updated
January 7, 2014
Record last verified: 2014-01